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Adenomyosis is a common gynecological condition that affects women, causing menstrual disturbances,
pain, and subfertility. Adenomyomectomy as an alternative to hysterectomy has been widely performed
in those who have not completed childbearing or those refusing a hysterectomy for a variety of reasons.
Whichever the surgical route, the challenges of adenomyomectomy include possible misdiagnosis,
deﬁning the extent of resection, technical difﬁculties, dealing with the associated complications, and
managing the risks of uterine rupture during a subsequent pregnancy. The principles of surgery mimic
those of myomectomy, but the evolution of adenomyomectomy has been relatively unexciting with a
general paucity of published data to date. Laparoscopic techniques have proven feasible generally,
avoiding the risks of open surgery while conferring the beneﬁts of microsurgery. Limitations in tactile
feedback and access constraints have been the main drawbacks via this route. Meticulous stitching and
repair is still of paramount importance in these operations. Preoperative gonadotropin-releasing hor-
mone agonists have proven effective in shrinking the disease and reducing blood loss during surgery,
whereas the postoperative use has resulted in a dramatic reduction in symptoms. Uterine artery ligation
techniques have also been shown to be useful adjuncts, although we still need to be mindful of the
potential effects in those desiring fertility. Furthermore, there is still no foolproof way in predicting those
at risk of uterine rupture after adenomyomectomy. Hence, a nonprescriptive approach in managing
adenomyomas is advised, where proper patient selection and counseling are important.
Copyright © 2015, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Adenomyosis is a benign gynecological condition characterized
by the presence of endometrial glands and stroma within the
uterine musculature. It is usually diagnosed in multiparous women
during the 5th decade of life1 and is thought to affect 1% of the fe-
male population.2 Womenwith adenomyosis can be asymptomatic
or present with symptoms of menorrhagia, dysmenorrhea, and
subfertility.
Adenomyosis can either be diffuse or focal, and the etiology and
pathogenic mechanism of adenomyosis are poorly understood.
Most studies favor the theory of endomyometrial invagination of
the endometrium.3 Other theories include de novo development of
adenomyosis from embryological misplaced pleuripotent mulle-
rian remnant, invagination of the basalis proceeding along thepartment, Reproductive Sur-
Bukit Timah Road, 229899
n).
for Gynecologic Endoscopy and Minimintramyometrial lymphatic system, or origination from bone
marrow stem cells that are displaced through the vasculature.4
Hysterectomy remains the mainstay of treatment. However,
conservative surgical management in the form of adenomyomec-
tomy remains the recommended treatment for those who have not
completed their childbearing.
The evolution of adenomyomectomy as a surgery has largely
been “unexciting,” and there is a general paucity of data. Hyama5
introduced the ﬁrst reported case of open adenomyomectomy in
1952. From 2000 onward, there was a move toward the concept of
“radicalizing excision” and the introduction of laparoscopic tech-
niques. In more recent years, evolution of endoscopy itself has
resulted in ﬁrst reported case of robot-assisted laparoscopic tech-
nique for adenomyomectomy.6
Challenges faced with adenomyomectomy
Diagnosis
Making an accurate diagnosis of adenomyoma is not straight-
forward, with it being frequently misdiagnosed as ﬁbroids onally Invasive Therapy. Published by Elsevier Taiwan LLC. All rights reserved.
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sensitive test for the detection of adenomyosis; however, it is also
the most expensive, limiting access to afﬂuent health care sys-
tems.7 This inﬂuences the way in which patients are counseled
preoperatively and affects patients' outcomes achieved through
surgery.Extent of removal
Uncertainty in deﬁning the site and extent owing to a lack of
surgical plane makes it difﬁcult to determine the extent of com-
plete excision. One constantly needs to balance between inade-
quate removal of the adenomyoma versus excessive healthy
myometrial excision that is detrimental to wound integrity.Technical difﬁculties
The excision of ill-deﬁned, tough adenomyotic tissue via lapa-
roscopy is often difﬁcult owing to a lack of tactile feedback. Robust
suturing is also needed to close the defect while preventing the
tearing of tissues. Techniques that have been recommended to
enhance the strength of the sutures include the use of mono-
ﬁlament sutures, taking deep bites of the myometrium to prevent
dead space formation and using interrupted sutures to reduce
tension on the wound.Associated complications
Potential complications of adenomyomectomy include intra-
operative hemorrhage, postoperative formation of intra-abdominal
adhesions that may cause pain or contribute to infertility, uterine
rupture in future pregnancies, as well as recurrence of the
pathology.Pregnancy after adenomyomectomy
Preventing tubal damage is of paramount importance in pa-
tients desiring fertility. The uterine cavity should remain intact to
allow for implantation. The uterine wall must be properly recon-
structed to enable it to sustain fetal growth following conception,
and adhesions should be minimized postoperatively as these may
have an effect on fertility outcomes.
The removal of a signiﬁcant amount of myometrium in adeno-
myomectomy leads to two problems. First, there is a reduction in
myometrial capacity of the uterus during pregnancy. Second, the
presence of a uterine scar may reduce tensile strength, thereby
predisposing future pregnancies to an increased risk of uterine
rupture.Surgical techniques
The rationale for adenomyomectomy includes that of cytor-
eduction, debulking to relieve the mechanical disturbances, and
correcting physiological disturbances that may impair sperm
transport.
The established surgical principles of myomectomy are
extended to adenomyomectomy with some key exceptions. For
one, an anterior incision to minimize blood loss and keep the
ovaries from adhering to the posterior wall of the uterus post-
operatively may not always be possible. Also, the plane of an ade-
nomyoma is often difﬁcult to establish owing to the lack of clear
demarcation between normal and diseased tissue, unlike that of a
myoma.Open technique
This is often regarded as the gold standard for the treatment of
extensive disease, and is one that has been traditionally used.
However, an open approach subjects the patient to risks and
morbidity of open surgery, with it being less cosmetically
appealing.
Laparoscopic technique
Laparoscopic gynecological surgery was developed to avoid
laparotomy and its risks. It also allows for microsurgical principles
to be applied, resulting in greater operative precision and reduction
in trauma, adhesions, and bleeding.
Traditionally, laparoscopic adenomyomectomy is performed via
wedge resection where the part of the seromuscular layer where
the adenomyoma is located is removed. In this procedure, some of
the adenomyotic tissue may remain on either side of the incision.
Part of the muscle layer is then sutured, the tumor cavity is closed
with absorbable sutures, and the residual seromuscular layer is
sutured.
Surgical modiﬁcations to the traditional wedge resection have
been developed to decrease complications and intraoperative
blood loss, and the surgical techniques involved in laparoscopic
modiﬁed adenomyomectomy are some of these modiﬁcations. The
procedure of laparoscopic modiﬁed adenomyomectomy was
described in a paper published in 2011 by Sun et al.8 Here, the
uterine serosa is subjected to bipolar coagulation, and the uterine
muscle is transversely cut by a unipolar incision of the adenoma-
tous tissue. The adenomatous tissue is then resected until it is soft,
at which time the assistant ﬁxes the adenomatous tissue with
grasping forceps. Hemostasis is achieved by use of electric coagu-
lation. The “cave-like” wound is ﬂushed, the tumor cavity is closed
by U-shaped suturing of the muscle layer, and the seromuscular
layer is closed by ﬁgure-of-eight sutures spaced at 1 cm.
The ongoing challenge with laparoscopy is how to excise
enough diseased adenomyotic tissue laparoscopically while
ensuring proper closure. A laparoscopic approach, associated with
poorer operative access, does not allow for tactile feedback, thereby
limiting the assessment of the extent of disease. This is aggravated
by the presence of adhesions or an enlarged globular uterus.
Therefore, technical constraints may be met when extensive
excising and suturing is required.
The case series published byMorita et al9 in 2004 included three
women with focal adenomyosis that was excised laparoscopically.
The lesions were preoperatively delineated with MRI, and all three
patients involved received leuprolide acetate (1.88 mg) for 3e4
months preoperatively. There were no reported complications, and
the average blood loss was 53.3 mL. The patients' symptoms dis-
appeared by the ﬁrst menstrual period after surgery. In this paper,
the authors had highlighted that the most important point was to
ensure precise diagnosis and evaluation of the adenomyosis pre-
operatively by MRI.
A radical excision technique was reported by Takeuchi et al10 in
2006. Essentially, in this particular technique, a ﬂap was created
and sutured in an overlapping manner to ﬁll in the dead space after
excision. Fourteen women with symptomatic adenomyosis with a
size of 30 mm or greater on MRI were included in the trial. Nine
cases were administered gonadotropin-releasing hormone agonists
(GnRHa; leuprolide acetate), and one case was administered oral
contraceptives. Postoperatively, the median visual analog scale
score during menstruation signiﬁcantly decreased (p < 0.01) from
10 (range, 9e10) prior to the operation to 2.5 (range, 1e6) after the
operation. All eight cases of polyhypermenorrhea improved after
the operation.
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nomyomectomy in 2008, where the authors concluded that lapa-
roscopic management appears to be safe and feasible with good
follow-up results and limited recurrence rates. Table 1 illustrates
the papers that have been published sinceMorita et al's9 report was
published in 2004. In essence, these results do validate that there is
indeed a role for laparoscopy in modern-day treatment of
adenomyomas.
Comparing open versus laparoscopic approach
Currently, there are no known published studies comparing
outcomes between the open and laparoscopic approach to adeno-
myomectomy. However, robust evidence is available for myomec-
tomy procedures. A systematic review published in 2009
comparing open versus laparoscopic myomectomy showed that
laparoscopic myomectomy was associated with less hemoglobin
drop, reduced operative blood loss, more patients fully recuperated
at Day 15, diminished postoperative pain, and fewer overall com-
plications but longer operation time with comparable major com-
plications, pregnancy, and recurrence rates in both groups.12 To
examine if the same outcomes seen in myomectomies are appli-
cable to adenomyomectomies, more studies need to be conducted
looking speciﬁcally at adenomyomectomies.
Reducing adenomyomectomy risks during laparoscopy
This is primarily through a combination of surgical techniques
and the utilization of adjuvants before or after the operation.
Hemorrhage
Preoperative GnRHa
There is a strong evidence for hormonal manipulation in the
treatment of adenomyoma-related diseases.13
GnRHa have been used for the treatment of adenomyoma-
related diseases, resulting in a reduction in uterine size and
symptomatic improvement. However, this effect is often transient
and most patients will experience a recurrence of their symptoms;
therefore, there is a need for deﬁnitive treatment such as adeno-
myomectomy. This drug is primarily used preoperatively to
decrease the size of the lesion, facilitate resection, and reduce
intraoperative bleeding. Morita et al9 had documented an average
of 53.3 mL of blood loss when GnRHa was used prior to resecting
the adenomyomas. With reference to Table 1, this is perhaps one of
the more effective ways to decrease blood loss.
Vasopressin
Vasopressin acts by constricting the smooth muscle in the walls
of capillaries, small arterioles, and venules. Currently, there is noTable 1
Studies indicating the feasibility of laparoscopic adenomyomectomy.
Study Cases Average size of lesion Average operating ti
Morita et al9 3 5.83 cm 91.7
Takeuchi et al10 14 24 g 101.5
Grimbizis et al11 6 5 cm 100.5
Wang et al35 2 4.25 cm NR
Sun et al8 13 4.4 cm 91
Kang et al23 37 60 g 115.7
Overall 61 4e6 cm 99.7
GhRH ¼ gonadotropin-releasing hormone; NA ¼ not applicable; NR ¼ not reported.available concrete evidence that the use of vasopressin reduces
blood loss in adenomyomectomy procedures speciﬁcally. However,
the role of vasopressin has beenwell established inmyomectomies.
Randomized trial data have shown that blood loss during myo-
mectomy with vasopressin is signiﬁcantly less than with placebo
(299 mL less),14 and less than or comparable to use of a uterine
artery tourniquet.15e17 Injecting vasopressin diluted in normal sa-
line prior to making the incision on adenomyoma helps to decrease
bleeding from the incision for about 20 minutes. However, it has
beenmentioned in the literature that possible drawbacks of the use
of vasopressin in laparoscopic myomectomy include bleeding from
the needle puncture sites, which often persists throughout the
procedure, requiring later electrosurgical coagulation, and delayed
bleeding in the myometrium.18 One needs to maintain vigilance in
achieving hemostasis even when using vasopressin because of the
risk of delayed bleeding, thereby rendering a false sense of security.Oxytocin infusion
Oxytocin acts directly on the myometrium via its receptors on
the uterine smooth muscle cells, stimulating contraction of the
uterus and diminishing uterine perfusion. Oxytocin receptors also
exist in the nonpregnant uterus,19 albeit in lower concentrations
than its pregnant counterpart.20 A study by Wang et al21 demon-
strated that intraoperative infusion of oxytocin signiﬁcantly re-
duces blood loss in cases of laparoscopic myomectomy. Currently,
there are no existing studies looking at the efﬁcacy of oxytocin
infusion in adenomyomectomy. Therefore, the routine use of
oxytocin during adenomyomectomy cannot be advocated.Defect closure
Meticulous and quick stitching for closure by experienced sur-
geons is the most deﬁnitive way to lessen intraoperative blood loss
after adenomyomectomy. As in myomectomy, the resulting defect
is usually closed with absorbable sutures in one or multiple layers
in an interrupted or continuous sequence. The key idea is to close
up all the dead spaces so that hematoma formation does not occur.
A useful trick is to approximate the edges with U-shaped su-
tures, as demonstrated in Figs. 1A and 1B. This approximation
serves to reduce tearing of the tissue and reduce tension prior to
deﬁnitive closure. Sun et al8 reported a trend toward decreased
blood loss (137 ± 154 mL vs. 216 ± 255 mL; p ¼ 0.066) when a U-
shaped stitch was placed in the manner described above. The
simple explanation could be that the central stitch helped reduce
the blood loss through a tamponade effect almost immediately.Laparoscopic uterine artery occlusion or ligation
The uterus is supplied by the uterine artery, a branch from the
anterior division of the internal iliac artery. When occluded,me (min) Average blood loss (mL) Adjuvants
53.3 Preoperative GnRH agonist
225 Preoperative GnRH agonist ( 9)
Oral contraceptive pill ( 1)
163 Nil
NR Oxytocin infusion for 1 patient
216 Nil
80.0 Uterine artery occlusion
NA NA
Fig. 1. (A, B) Application of U-shaped sutures to approximate the edges of the ade-
nomyomectomy incision.
Fig. 2. (A) Ligation of uterine arterydanterior approach. (B) Ligation of uterine
arterydposterior approach.
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sively in myomectomy procedures to reduce the blood loss.
The uterine arteries can be ligated by an anterior approach or
posterior approach.22 In the anterior approach, the uterovesical fold
of the peritoneum is ﬁrst opened and the bladder is pushed down,
moving the ureters laterally to prevent them from being included in
the sutures (Fig. 2A). The uterine vessels are identiﬁed on either
side and ligated. In the posterior approach, the uterine artery can be
ligated at its origin from the anterior division of the internal iliac
after opening the triangle enclosed by the round ligament, external
iliac artery, and infundibulopelvic ligament (Fig. 2B).
A retrospective cohort study published by Kang et al23 looked at
the role of uterine artery occlusion in laparoscopic adenomyo-
mectomy. Thirty-seven patients were treated with uterine artery
occlusion via the posterior approach, combined with partial
resection of adenomyosis via laparoscopy. No severe complications
were noted during the surgical procedure or follow-up. The mean
surgical time was 115.7 ± 27.5 minutes (mean ± SD, range 61e171
minutes), and the mean blood loss was 90.0 ± 35.2 mL (range
50e150 mL). At 6 months after surgery, the volume of the uterus
shrank 24.7% compared with preoperative volume, and the
shrinkage rate was 59.2% at 12 months after surgery.
Studies on uterine artery embolization have stated the possi-
bility of ovarian failure following the procedure.24 Other studiessuggest that, unlike uterine artery embolization, uterine artery
occlusion is a selective procedure and does not cause decreased
ovarian reserve. Qu et al25 conducted a study to assess the effect of
ovarian reserve function after laparoscopic uterine artery occlusion,
and found that postoperative serum concentrations of follicle-
stimulating hormone, luteinizing hormone, and inhibin B in the
study group that underwent laparoscopic uterine artery occlusion
with myomectomy were not signiﬁcantly different (p > 0.5). When
planning surgery for patients desiring fertility, a comprehensive
discussionwith the patient should be conducted in view of the lack
of deﬁnitive studies on the effect of uterine artery ligation on future
fertility.
Use of tourniquets
There are currently no studies looking speciﬁcally at the use of
tourniquets for reduction of blood loss in adenomyomectomy
procedures. However, the use of tourniquets for occlusion of uter-
ine blood supply has been studied in open myomectomy pro-
cedures and has been shown to reduce intraoperative blood loss.
The beneﬁt of using of a uterine artery tourniquet was illustrated in
a randomized trial of 28 women.26
Although there has been a lack of studies looking at tourniquet
use in adenomyomectomy, a recent prospective study published in
2013 examined the outcomes of surgical technique of laparoscopic
adenomyomectomy with transient occlusion of uterine artery in
patients with symptomatic uterine adenomyoma.27 In this study,
occlusion of the uterine arteries was done using an endoscopic
vascular clip instead of a tourniquet. Themean estimated blood loss
was 148.18 ± 93.99 mL, no injury to the uterine arteries or pelvic
nerves occurred, and no cases of conversion to a laparotomy or
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scopic adenomyomectomy with transient occlusion of uterine ar-
tery could be a safe and effective surgical fertility-preserving
method for womenwith symptomatic uterine adenomyoma. Going
by the same principles of occlusion of the uterine arteries, an
alternative method of occlusion with tourniquets could produce
similar reductions in blood loss.
Timing of surgery
Currently, there are no studies looking at the relationship be-
tween timing of adenomyomectomy with regard to the menstrual
cycle and intraoperative blood loss, but it is the authors' opinion
that the procedure should be performed during the follicular phase
of the menstrual period. In addition to preventing the risk of sur-
gery being performed during an undiagnosed luteal phase preg-
nancy, it has been suggested that the timing of surgery in relation to
the menstrual cycle may have an impact on intraoperative blood
loss.
A randomized controlled trial by Paraskevaidis et al28 compared
the outcomes between patients treated with the loop electrosur-
gical excision procedure during different phases of the menstrual
cycle. It was shown that women treated during the luteal phase
experienced signiﬁcantly more postoperative bleeding. One
postulation is that vaginal and pelvic microvessels exhibit
increased vascular reactivity during the follicular phase, which al-
lows for better contraction of these microvessels and better
hemostasis.
Adhesions
Postoperative adhesions can lead to morbidities such as pain,
secondary subfertility, and increased risk of complications in sub-
sequent operations. Although the incidence of adhesions after
excision of adenomyomas has not been reported, antiadhesion
agents such as Interceed and Sepraﬁlm are still widely used in
various types of gynecological surgeries.
Uterine rupture in pregnancy
The expansile capacity of the pregnant uterus depends mostly
on an increase in plasticity rather than elasticity,29,30 and the main
factor determining the increase in plasticity is the collagenous
framework of connective tissue.31
The safety proﬁle for pregnancy is more deﬁned in laparoscopic
myomectomy compared with laparoscopic adenomyomectomy,
because the capsule of the myoma demarcates it from normal
myometrium. After enucleation and repair of the cavity, the uterus
is similar to its original state except for the additional presence of a
scar. In adenomyomectomy, it involves actual excision of myome-
trium ﬁbers, and the resultant uterine scar may also contain foci of
adenomyoma that may contribute to weakening of the scar. In this
way, repair of the uterus may be less than optimal.
In 2006, Wada et al32 published a case report of a spontaneous
uterine rupture of a twin pregnancy after in vitro fertilization at 30
weeks of gestation. The patient had suffered from diffuse adeno-
myosis, and 160 g of adenomyotic fragments was excised posteri-
orly before closure in two layers. Morimatsu et al33 reported a
similar case of rupture at 28 weeks' gestation, where the patient
had undergone a laparoscopic wedge excision for a localized ade-
nomyoma through an incision made in the posterior uterine wall. A
single-layer suture repair was performed, and she conceived
spontaneously 1 month later.
At present, reports of uterine rupture after adenomyomectomy
are scarce, and the true incidence of rupture is yet unknown.Whether factors such as the size of adenomyoma excised, different
stitching techniques, or time to conception after adenomyomec-
tomy affect the risk of uterine rupture is also an unknown. Never-
theless, in view of the debatable beneﬁts of adenomyomectomy if
fertility is desired, patients should be counseled preoperatively
about the possibility of uterine rupture in future pregnancies so
that they may be better informed.
Combined surgicalemedical treatment
Adenomyomectomy should not be the be-all and end-all in
managing adenomyomas. Prior to making a decision to undertake
operative adenomyomectomy, one should consider if conservative
medical treatment may alleviate the patient's symptoms without
subjecting her to the risks of surgery. In cases where adenomyo-
mectomy has been deemed to be the best management option,
consideration should be given to the use of adjuvant medical
therapy postoperatively to improve patient outcomes. A study
found that a combined surgicalemedical treatment in managing
symptomatic uterine adenomyomas provided more effective
symptom control and a lower symptom relapse rate during a 2-year
follow-up period.34
Robotic adenomyomectomy
Following the ﬁrst case report,6 robotic adenomyomectomy
widens the options available for excision of localized adenomyosis.
At present, robot technology helps in bridging the learning-curve
gap between the open and laparoscopic approach. However, aside
from the additional drawback of increased operative costs, the
challenges inherent to laparoscopy as highlighted earlier are still
not fully addressed in robotic surgeries.
Conclusion
The beneﬁts of adenomyomectomy have not yet been deﬁni-
tively established in high-quality studies; therefore, a non-
prescriptive approach in managing adenomyomas is
recommended. The careful selection of patients is essential to
minimize unnecessary morbidities. Proper counseling of patients
should include discussions on potential risks and impact on future
fertility. The surgical techniques and adjuvants to be used should be
varied depending on the patient and disease proﬁle.
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